| Authors: |
Phadnis S; Division of Pediatrics, Children's of Alabama at The University of Alabama, Birmingham., Wang X; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston., Daw NC; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston., Herzog CE; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston., Subbiah IM; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston; Sarah Cannon Research Institute (SCRI), Nashville., Zaky W; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston., Gouda MA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston., Morani AC; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston., Amini B; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston., Harrison DJ; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston., Piha-Paul SA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston., Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston., Gorlick R; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston., Schwartz CL; Children's Hospital of Wisconsin, Milwaukee, USA., Subbiah V; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston; Sarah Cannon Research Institute (SCRI), Nashville. Electronic address: Vivek.Subbiah@scri.com. |
